On May 27, 2025, analyst Andrew Fein from HC Wainwright & Co. maintained a 'Buy' rating for Prothena Corp (PRTA, Financial), while simultaneously lowering the price target from USD 30.00 to USD 14.00.
This adjustment represents a significant decrease of 53.33% in the price target for PRTA. Despite the lowered price target, the 'Buy' rating indicates continued confidence in Prothena Corp's potential for future growth from the analyst's perspective.
Prothena Corp (PRTA, Financial), listed on NASDAQ, continues to be closely watched by investors following this updated analyst report. The revised price target and maintained 'Buy' rating may influence investor sentiment and trading strategies for the company's stock.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 8 analysts, the average target price for Prothena Corp PLC (PRTA, Financial) is $36.00 with a high estimate of $81.00 and a low estimate of $6.00. The average target implies an upside of 447.11% from the current price of $6.58. More detailed estimate data can be found on the Prothena Corp PLC (PRTA) Forecast page.
Based on the consensus recommendation from 10 brokerage firms, Prothena Corp PLC's (PRTA, Financial) average brokerage recommendation is currently 2.4, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Prothena Corp PLC (PRTA, Financial) in one year is $28.79, suggesting a upside of 337.54% from the current price of $6.58. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Prothena Corp PLC (PRTA) Summary page.
